21. Species identification of dermatophytes in paraffin‐embedded biopsies with a new polymerase chain reaction assay targeting the internal transcribed spacer 2 region and comparison with histopathological features. (26th December 2015) Authors: Eckert, J.C.; Ertas, B.; Falk, T.M.; Metze, D.; Böer‐Auer, A. Journal: British journal of dermatology Issue: Volume 174:Number 4(2016) Page Start: 869 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
22. Successful monotherapy of pemphigus vegetans with minocycline and nicotinamide. (7th September 2016) Authors: von Köckritz, A.; Ständer, S.; Zeidler, C.; Metze, D.; Luger, T.; Bonsmann, G. Journal: Journal of the European Academy of Dermatology and Venereology Issue: Volume 31:Number 1(2017:Jan.) Page Start: 85 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
23. Successful treatment of lichen amyloidosis using capsaicin 8% patch. (22nd April 2015) Authors: Zeidler, C.; Metze, D.; Ständer, S. Journal: Journal of the European Academy of Dermatology and Venereology Issue: Volume 30:Number 7(2016:Jul.) Page Start: 1236 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
24. The mammalian target of rapamycin inhibitor everolimus suppresses proliferation, metabolic activity and collagen synthesis of human fibroblasts in vitro and exerts antifibrogenic effects in vivo. (1st October 2017) Authors: Böhm, M.; Stegemann, A.; Metze, D.; Scharffetter‐Kochanek, K.; Sindrilaru, A. Journal: British journal of dermatology Issue: Volume 177:Number 4(2017) Page Start: e130 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
25. The mammalian target of rapamycin inhibitor everolimus suppresses proliferation, metabolic activity and collagen synthesis of human fibroblasts in vitro and exerts antifibrogenic effects in vivo. (10th September 2017) Authors: Böhm, M.; Stegemann, A.; Metze, D.; Scharffetter‐Kochanek, K.; Sindrilaru, A. Journal: British journal of dermatology Issue: Volume 177:Number 4(2017) Page Start: e130 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
26. The mammalian target of rapamycin inhibitor everolimus suppresses proliferation, metabolic activity and collagen synthesis of human fibroblasts in vitro and exerts antifibrogenic effects in vivo. (1st October 2017) Authors: Böhm, M.; Stegemann, A.; Metze, D.; Scharffetter‐Kochanek, K.; Sindrilaru, A. Journal: British journal of dermatology Issue: Volume 177:Number 4(2017) Page Start: e130 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗